NEOGENOMICS, INC. (NEO) Gross margin 2016–2025
NEOGENOMICS, INC. (NEO) gross margin by fiscal year — reported gross profit divided by reported revenue.
43.2%FY2025 · since FY2016: 42.3% → 43.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 43.2% | -0.7 pp |
| FY2024 | 43.9% | +2.6 pp |
| FY2023 | 41.3% | +4.5 pp |
| FY2022 | 36.9% | -1.8 pp |
| FY2021 | 38.6% | -3.2 pp |
| FY2020 | 41.8% | -6.3 pp |
| FY2019 | 48.1% | +2.2 pp |
| FY2018 | 46.0% | +3.5 pp |
| FY2017 | 42.4% | +0.1 pp |
| FY2016 | 42.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice